The American Diabetes Association has published updated Standards of Care in Diabetes guidelines which includerevisions to incorporate person-first and inclusive language. 

Updates include: 

• New updates in managing obesity in people with diabetes, including approaches to reduce therapeutic inertia, support more  personalisation, and incorporate additional obesity measurements beyond BMI (ie. body fat distibution measurements) 

• New screening recommendations for heart failure in people with diabetes

• Guidance on screening and the use of teplizumab, approved to delay the onset of type 1 diabetes  

• More guidance on the use of new obesity medications to reach sustained weight management goals 

• Updates in guidance on the diagnosis and classification of diabetes 

• A focus on hypoglycemia prevention and management 

• Emphasis on screening people with diabetes for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis at primary care and diabetes clinics 

• New emphasis on the evaluation and treatment of bone health and added attention to diabetes-specific risk factors for fracture. 

• A focus on screening and management of people with diabetes and disability.  

• New information on the possible association between Covid-19  infection and new onset of type 1 diabetes. 

Further details on the ADA website: professional.diabetes.org